Filter results
Type
Audience
Last updated
Topics
-
Australian Health Protection Principal Committee (AHPPC) statement on strategic direction
News and media24 July 2020 - The AHPPC recommends that the goal for Australia is to have no community transmission of COVID-19, strengthening the current suppression strategy and updating metrics.
-
Bulk Billing for all Australians – How to access bulk billing – Auslan video
Resources29 April 2026 - This animated video includes Auslan interpretation and explains what bulk billing is, how to find practices participating in the Bulk Billing Practice Incentive Program and how Medicare can cover your next GP visit.
-
Australian Health Protection Principal Committee (AHPPC) coronavirus (COVID-19) statements on 14 May 2020
News and media9 July 2020 - 3 statements from the Australian Health Protection Principal Committee about COVID-19.
-
Hospitals and other sites that bulk bill primary care in rural and remote areas
Our work › COAG Section 19(2) Exemptions Initiative – Improving Access to Primary Care in Rural and Remote Areas30 March 2026 - Find out which public hospitals and multipurpose services provide bulk-billed primary care in rural and remote areas under the COAG Section 19(2) Exemptions initiative.
-
Private Health Insurance clinical category definitions 1 March 2026
Resources › Publications12 February 2026 - Standard clinical category definitions for private health insurance hospital policies, released on 13 February 2026 and effective 1 March 2026.
-
Life Saving Drugs Program – Gaucher disease (type 1) – Guidelines
Resources › Publications11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Gaucher disease (type 1) under the Life Saving Drugs Program.
-
Life Saving Drugs Program – Sebelipase alfa (Kanuma®) outcome statement
Resources › Publications11 June 2025 - Summary of the consideration of the application from Alexion Australia for the inclusion of sebelipase alfa (Kanuma®) on the LSDP for the treatment of infantile onset lysosomal acid lipase deficiency (LAL-D).
-
Changes to the Prostheses List timeframes (2023/24)
Resources › Videos23 January 2026 - This webinar recording provides an overview of the timing and impact of bypassing the March 2024 update and information on the Prostheses List reforms planned for 2023.
-
Life Saving Drugs Program – Mucopolysaccharidosis type I (MPS I) – Guidelines
Resources › Publications11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type I (MPS I) under the Life Saving Drugs Program.
-
Life Saving Drugs Program – Mucopolysaccharidosis type II (MPS II) – Guidelines
Resources › Publications11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type II (MPS II) under the Life Saving Drugs Program.